摘要 |
<p>The present invention relates to the field of central nevous system (CNS) research. Demyelination of neuronal axons within the CNS underlies the pathogenesis of degenerative diseases of the neuromuscular system, such as multiple sclerosis and hereditary leukodystrophies. Therefore, treatments aimed towards accelerating the repair of myelin sheaths offer a potential therapeutic to ameliorate the symptoms of multiple sclerosis and leukodystrophies. A compound, globular OBG3, has been identified that has immunosuppressive properties. This compound should be effective for accelerating the rate of remyelination and treating multiple sclerosis and leukodystrophies.</p> |